Table 4.
Summary of the main results in univariate and multivariate analysis.
| dcSSc | mRSS | ΔmRSS | PH | ILD | FVC | DLCO | ΔFVC | ΔDLCO | ILD Progressors | |
|---|---|---|---|---|---|---|---|---|---|---|
| White blood cells (G/L) | ||||||||||
| Monocytes (G/L) | * | |||||||||
| Neutrophils (G/L) | * | |||||||||
| Eosinophils (G/L) | ||||||||||
| Hemoglobin (g/dL) | * | |||||||||
| Platelets (G/L) | * | |||||||||
| CRP (mg/L) | * | |||||||||
| ESR (mm/h) | ||||||||||
| NTproBNP (ng/L) | * | |||||||||
| Uric acid (mg/L) | ||||||||||
| Ferritin(ng/mL) | ||||||||||
| AST (UI/L) | ||||||||||
| ALT (UI/L) | ||||||||||
| ALP (UI/L) | ||||||||||
| GGT (UI/L) | ||||||||||
| Total bilirubin (mg/L) | ||||||||||
| Serum potassium (mmol/L) | ||||||||||
| Urea (g/L) | ||||||||||
| Creatinin (mg/L) | ||||||||||
| A1globulins (g/L) | ||||||||||
| A2globulins (g/L) | ||||||||||
| Betaglobulins (g/L) | * | |||||||||
| Gammaglobulins (g/L) | * | |||||||||
| Albumin (g/L) | * | * | * | |||||||
| Lymphocytes (G/L) | ||||||||||
| Basophils (G/L) | ||||||||||
| Serum sodium (mmol/L) |
dcSSc: diffuse cutaneous systemic sclerosis; mRSS: modified Rodnan skin score; pH: pulmonary hypertension; ILD: interstitial lung disease; %FVC: forced vital capacity (% predicted value); %DLCO: carbon monoxide lung diffusion capacity; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; NTproBNP: N-terminal pro-brain natriuretic peptide; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gammaglutamyltranspeptidase; ALP: alkaline phosphatase. * Significant results in multivariate analysis. Δ Relative progression mRSS, FVC and DLCO.
Positive significant association.
Negative significant association.
No significant association.
CRP was higher in patients with dcSSc but not significantly p = 0.064.